Zobrazeno 1 - 10
of 224
pro vyhledávání: '"Jean Pierre Marie"'
Autor:
Pierre Hirsch, Ruoping Tang, Christophe Marzac, Jean-Yves Perrot, Fanny Fava, Chantal Bernard, Dorota Jeziorowska, Jean Pierre Marie, Ollivier Legrand
Publikováno v:
Haematologica, Vol 97, Iss 2 (2012)
ATP-binding cassette transporter (and specially P-glycoprotein) activity is a well known prognostic factor in acute myeloid leukemia, but when compared to other molecular markers its prognostic value has not been well studied. Here we study relations
Externí odkaz:
https://doaj.org/article/c44d0bfaa0694d48a26e4d17f6d98428
Autor:
Yan, Lily D., Sufra, Rodney, St Sauveur, Reichling, Jean-Pierre, Marie Christine, Pierre, Jean Lookens, Apollon, Alexandra, Malebranche, Rodolphe, Théard, Michel, Pierre, Gerard, Dévieux, Jessy, Lau, Jennifer, Mourra, Nour, Metz, Miranda, Smith, Caleigh, Sabwa, Shalom, Clermont, Adrienne, Roberts, Nicholas L.S., Rasul, Rehana, Nash, Denis, Pirmohamed, Altaf M., Devereux, Richard B., Lee, Myung Hee, Kwan, Gene F., Safford, Monika, Adrien, Lauré, Alfred, Jean Patrick, Deschamps, Marie, Severe, Patrice, Fitzgerald, Daniel W., Pape, Jean W., Rouzier, Vanessa, McNairy, Margaret L., Safford, Monika M.
Publikováno v:
In The Lancet Regional Health - Americas May 2024 33
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Dunbar, Willy1,2 (AUTHOR) willy.junior.dunbar@ulb.be, Alcide Jean-Pierre, Marie Colette3 (AUTHOR), Pétion, Jacky S.4 (AUTHOR), Labat, Aline1 (AUTHOR), Maulet, Nathalie5 (AUTHOR), Coppieters, Yves1 (AUTHOR)
Publikováno v:
AIDS Research & Therapy. 10/9/2021, Vol. 18 Issue 1, p1-20. 20p.
Autor:
Dunbar, Willy1 wdunbar@ulb.ac.be, Alcide Jean-Pierre, Marie Colette2, Raccurt, Christian2, Pape, Jean William3, Coppieters, Yves1
Publikováno v:
International Journal of Medical Education. 2020, Vol. 11, p233-239. 7p.
Autor:
Marian Stevens-Kroef, Giovanna Meloni, Simona Sica, Xavier Thomas, Jean-Pierre Marie, Anne Hagemeijer, Constantijn J.M. Halkes, Adriano Venditti, Francesco Albano, Marco Mancini, Joop H. Jansen, Roelof Willemze, Radovan Vrhovac, Stefan Suciu, François Lefrère, Theo de Witte, Michal Kicinski, Petra Muus, Frédéric Baron, Sergio Amadori
Publikováno v:
Haematologica, 104, 1168-1175
Haematologica, 104(6), 1168-1175. FERRATA STORTI FOUNDATION
Haematologica
Haematologica, 104, 6, pp. 1168-1175
Haematologica, 104(6), 1168-1175. FERRATA STORTI FOUNDATION
Haematologica
Haematologica, 104, 6, pp. 1168-1175
Monosomal karyotype confers a poor prognosis in patients with acute myeloid leukemia. Here, we determined the impact of the type of remission-induction chemotherapy and the impact of having a donor in younger acute myeloid leukemia patients with a mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::650607fb266ca1f785c6ccd6b7b4b837
https://hdl.handle.net/2066/204593
https://hdl.handle.net/2066/204593
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Walter J.F.M. van der Velden, Laura Cannella, Theo de Witte, Jean-Pierre Marie, Maria Concetta Petti, Dario Ferrero, Edoardo La Sala, Sebastian Wittnebel, Paola Fazi, Roel Willemze, Marco Sborgia, Fabio Efficace, Sergio Amadori, Alberto Bosi, Marco Vignetti, Jean-Henri Bourhis, Francesco Fabbiano, Robert Zittoun, Frédéric Baron, Giovanni Martinelli, Petra Muus, Silvia Maria Trisolini, Stefan Suciu, Constantijn J.M. Halkes
Publikováno v:
Haematologica, 105, e13-e16
Haematologica, 105, 1, pp. e13-e16
Haematologica, 105, 1, pp. e13-e16
Contains fulltext : 218286.pdf (Publisher’s version ) (Open Access)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7b6d2a3951289b6bed33fd5e5d3e333
http://hdl.handle.net/2066/218286
http://hdl.handle.net/2066/218286
Autor:
Laura Cannella, Roelof Willemze, Constantijn J.M. Halkes, Marian Stevens-Kroef, Umberto Vitolo, Petra Muus, Xavier Thomas, Jean-Pierre Marie, Bernardino Allione, Sergio Amadori, Giorgina Specchia, Silvia Maria Trisolini, Fabio Efficace, Jose E. Guimaraes, Paola Fazi, Jean-Henri Bourhis, Edoardo La Sala, Radovan Vrhovac, Felicetto Ferrara, François Lefrère, Liv Meert, Marco Vignetti, Francesco Di Raimondo, Theo de Witte, Stefan Suciu, Patrizia Chiusolo, Walter J.F.M. van der Velden, Frédéric Baron
Publikováno v:
American Journal of Hematology, 95, 749-758
American Journal of Hematology, 95(7), 749-758. WILEY
American Journal of Hematology, 95, 7, pp. 749-758
American Journal of Hematology, 95(7), 749-758. WILEY
American Journal of Hematology, 95, 7, pp. 749-758
Contains fulltext : 220443.pdf (Publisher’s version ) (Closed access) We provide a long-term evaluation of patients enrolled in the EORTC/GIMEMA AML-10 trial which included a total of 2157 patients, 15-60 years old, randomized to receive either dau
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::637c0b9cc701c0a78475ccd7acceca15
https://doi.org/10.1002/ajh.25795
https://doi.org/10.1002/ajh.25795
Autor:
Guy Gammon, Jean Pierre Marie, Denise Trone, Stuart L. Goldberg, Martin S. Tallman, Giovanni Martinelli, Gary J. Schiller, Mark J. Levis, Alexander E. Perl, Hagop M. Kantarjian, Jorge E. Cortes
Publikováno v:
Blood, vol 132, iss 6
Cortes, JE; Tallman, MS; Schiller, GJ; Trone, D; Gammon, G; Goldberg, SL; et al.(2018). Phase 2b study of 2 dosing regimens of quizartinib monotherapy in FLT3-ITD-mutated, relapsed or refractory AML. BLOOD, 132(6), 598-607. doi: 10.1182/blood-2018-01-821629. UCLA: Retrieved from: http://www.escholarship.org/uc/item/1zw0t5wd
Cortes, JE; Tallman, MS; Schiller, GJ; Trone, D; Gammon, G; Goldberg, SL; et al.(2018). Phase 2b study of 2 dosing regimens of quizartinib monotherapy in FLT3-ITD-mutated, relapsed or refractory AML. BLOOD, 132(6), 598-607. doi: 10.1182/blood-2018-01-821629. UCLA: Retrieved from: http://www.escholarship.org/uc/item/1zw0t5wd
This randomized, open-label, phase 2b study (NCT01565668) evaluated the efficacy and safety of 2 dosing regimens of quizartinib monotherapy in patients with relapsed/refractory (R/R) FLT3-internal tandem duplication (ITD)-mutated acute myeloid leukem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9b1c036c9b2563ed059f05d29bb6bcd
https://doi.org/10.1182/blood-2018-01-821629
https://doi.org/10.1182/blood-2018-01-821629